Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria

Clinical trial NCT02166151 · UNKNOWN

Trial details

NCT number: NCT02166151
Sponsor: Rabin Medical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Idiopathic Urticaria

Start date: 2014-07-01
Primary completion: 2016-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.